| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Editorial |
1 Arizona Cancer Center, 2 Mel and Enid Zuckerman, Arizona College of Public Health, and 3 Department of Biochemistry and Molecular Biophysics, University of Arizona, Tucson, Arizona
Requests for reprints: Elizabeth T. Jacobs, Arizona Cancer Center, University of Arizona, P.O. Box 245024, Tucson, AZ 85724-5024. Phone: 520-626-0341; Fax: 520-626-9275. E-mail: jacobse{at}u.arizona.edu
The relationship of vitamin D with colorectal and other cancers is a rapidly expanding field of study. The pathway through which vitamin D exerts transcriptional effects is complex and involves the action of other nutrients. Recent epidemiologic work underscores the importance of considering the joint effects of calcium and vitamin D in studies of colorectal neoplasia (1, 2). A key feature of vitamin D is its role in maintaining calcium homeostasis, which further highlights the interrelationship of these nutrients. However, the action of a vitamin A derivative, 9-cis retinoic acid and its receptor, the retinoid X receptor (RXR), has seldom been investigated in epidemiologic studies of vitamin D, despite the importance of RXR to the transcriptional activity of the vitamin D receptor (VDR; ref. 3). The intricate biological relationship among these nutrients makes it difficult to assess their individual roles in the development of colorectal neoplasia. In this commentary, we present a pathway that outlines the independent and interactive effects of nutrients that impact vitamin D activity in the colorectum. Although the pathway that we present is relatively simplified, our purpose is to highlight the various gene-nutrient relationships that should be considered when conducting studies of vitamin D and colorectal cancer. In this context, we specifically emphasize the actions of 9-cis retinoic acid and RXR, two neglected factors in this pathway. Based on these actions, we recommend that future epidemiologic investigations consider the interrelationships of these nutrients and associated genetic polymorphisms, in addition to studying the effects of each individually.
As a brief introduction to the epidemiologic data for the action of vitamin D and related nutrients, there is epidemiologic support for a protective effect of vitamin D on risk of colorectal neoplasia (2, 4); however, the data are equivocal (5). For calcium, there are a wealth of prospective and clinical data indicating that this nutrient is associated with a lower risk of colorectal neoplasia (5-7). In a clinical trial conducted by Baron et al. (6), subjects assigned to daily supplementation with calcium carbonate had a significantly reduced risk of adenoma recurrence compared with the placebo group. Further analyses of this clinical trial revealed that higher serum 25-dihydroxyvitamin D levels were inversely associated with adenoma recurrence among participants in the calcium-supplemented group and not for those in the placebo group (1); this finding lends further support to the importance of the intricate biological relationship of these two nutrients to colorectal neoplasia (8). Although the role of calcium and vitamin D in colorectal carcinogenesis has been intensively investigated, the activity of 9-cis retinoic acid and RXR have not; this is in spite of the fact that RXR has been established as a component of vitamin D transcriptional activity. Nonetheless, putative protective mechanisms of action for 9-cis retinoic acid, calcium and vitamin D, and colorectal neoplasia have been proposed, as summarized in Fig. 1 and described below.
|
Investigations of the effects of 9-cis retinoic acid in the colon have been relatively sparse. Until recently, the role of RXR as an important regulatory component has been largely overshadowed by the potent effects of its heterodimer partners, including the peroxisome proliferator–activated receptor-
(23) and VDR (24). Nonetheless, 9-cis retinoic acid has been shown to inhibit growth of breast and bladder cancer cell lines (25, 26). In colon cancer cell lines, 9-cis retinoic acid has been shown to modify the antiproliferative response of 1,25-(OH)2D3, exhibiting an increased antiproliferative response in Caco-2 cells but blocking it in HT-29 cells (17). The reasons for these differential responses are unclear, but the data support a role for 9-cis retinoic as an important modulator of vitamin D activity. In addition to the pathways that describe the downstream biological activities induced by vitamin D, calcium, and 9-cis retinoic acid, the activity of related receptors and binding proteins for these nutrients must also be considered (Fig. 1).
The calcium-sensing receptor is necessary for the detection and maintenance of extracellular calcium levels by influencing parathyroid hormone secretion and calcium reabsorption (27). Calcium-sensing receptors may regulate the amount of calcium available to intestinal cells, and variation in the amount or activity of calcium-sensing receptors may have implications for colorectal carcinogenesis. Indeed, polymorphisms of this gene have been associated with risk of advanced stage rectal cancer (28).
The vitamin D-binding protein is important for the transport of the two major forms of circulating vitamin D, 25-(OH)D and 1,25-(OH)2D3 (29). Although this protein has been shown to be highly polymorphic, there have been few studies of its genetic variation and cancer. Following vitamin D transport to target tissues via vitamin D-binding protein, the VDR is critical to the action of 1,25-(OH)2D3 (3). After binding its ligand, VDR must heterodimerize with the RXR to exert transcriptional effects on target genes (24).
There are three isoforms of RXR (
, ß, and ), with abundant RXR expressed in normal and neoplastic colorectal tissue (30) and colorectal cancer cell lines (17). In addition, recent investigations have indicated an important role for RXR in colorectal pathogenesis, both independently and in conjunction with its heterodimer partners. RXR has been shown to have a role in decreasing colonic inflammation in mouse models (31). In addition, RXR may exert chemopreventive or chemotherapeutic effects in the colon via the regulation of ß-catenin (32). Dysregulation of ß-catenin is a common outcome of mutations observed in colorectal cancer, resulting in higher concentrations of ß-catenin and ultimately increased activation of oncogenes (32). RXR agonists have been shown to enhance interaction between RXR and ß-catenin, resulting in more efficient ß-catenin degradation and subsequent antiproliferative effects (32).
Alterations in the concentration or function of the receptors, binding proteins, or ligands presented in Fig. 1 could have major implications on actions within the cell. Polymorphic variation has been observed in several nuclear receptors (33, 34), including VDR, and has been shown to affect transcriptional activity (35). In addition, VDR polymorphisms have been associated with colorectal adenoma formation (36), as well as with risk of several types of cancer (37-39), although results have been equivocal (1, 2). Recently, polymorphic variation has been described in the gene for RXRß (34), a subtype of RXR expressed in several human tissues. As has been observed with VDR polymorphisms, variation in the gene for RXR may elicit functional changes that are important for colorectal cancer risk. Therefore, investigations to identify the functional effects of genetic variation in RXR and its role in the vitamin D pathway will be critical to further the understanding of the mechanism of action of vitamin D.
In summary, the involvement of several nutrients and genes in altering vitamin D activity strongly indicates the need for a pathway approach to the study of its biological effects, including greater emphasis on the activity of 9-cis retinoic acid and RXR. Study of the biological effects of RXR is an especially rich area for research, given its role as a heterodimer partner for several steroid nuclear receptors (40), including peroxisome proliferator–activated receptor- (23), a molecule that has itself been shown to have implications for colorectal carcinogenesis (41). We believe that examining vitamin D and/or VDR alone in epidemiologic studies, without consideration of additional key factors involved in the proposed pathway, may result in misleading or incomplete mechanisms of action. We have presented a simplified pathway to facilitate further discussion of well-known interactions among the nutrients and genes discussed. However, the vitamin D pathway is clearly more complex. Because this is a rapidly evolving field of cancer research, future studies will undoubtedly continue to uncover additional gene-gene and gene-nutrient interactions that will need to be considered along with factors proposed in the present work.
 |
Footnotes |
|---|
Received 7/12/05; accepted 7/26/05.
|
References |
|---|
 Top References |
|---|
,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 2001;15:1370–80. expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res 1997;57:2642–50. (PPAR) heterodimer. A basis for new therapeutic strategies. J Exp Med 2001;193:827–38. associated with human colon cancer. Mol Cell 1999;3:799–804.[CrossRef][Medline]This article has been cited by other articles:
|
|
 |
|
  N. B. Janakiram, I. Cooma, A. Mohammed, V. E. Steele, and C. V. Rao -Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-{alpha} in human colon cancer cells Mol. Cancer Ther., January 1, 2008; 7(1): 181 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C van der Pols, C. Bain, D. Gunnell, G. Davey Smith, C. Frobisher, and R. M Martin Childhood dairy intake and adult cancer risk: 65-y follow-up of the Boyd Orr cohort Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1722 - 1729. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
